04 - Neurosurgical / 04.05 - NEUROSTIMULATION THERAPIES FOR PAIN MANAGEMENT / 04.05.03 - Leads

04.05.03.01 - Permanent Lead · greater than 8 and less than 32 electrodes, Bifurcated proximal tail

5 devices · 3 sponsors

March 2027 window closes in 92 days

Median benefit

$8123.00

Range

$8123–8123

Comparator candidates

Code	Device · sponsor	Benefit	Tier 1 comparator?
BS312	Infinion CX Lead BOSTON SCIENTIFIC PTY LTD	$8123.00	eligible
BS441	Infinion Pro Lead BOSTON SCIENTIFIC PTY LTD	$8123.00	eligible
SJ231	Penta Leads ABBOTT MEDICAL AUSTRALIA PTY LTD.	$8123.00	eligible
WW016	Surpass-C Surgical Lead Nevro Medical Pty Ltd	$8123.00	eligible
WW022	Surpass Surgical Lead Nevro Medical Pty Ltd	$8123.00	eligible

5 device(s).

Tier pre-screener

Indicative only — pathway choice is the sponsor's responsibility.

TGA class of your device Well-established technology? Listing in this existing grouping? Interchangeable with a comparator here?

4-year benefit estimate

For the HPP utilisation section — arithmetic on your inputs.

Benefit $ Units/yr (low) Units/yr (high)

Year	Low	High
4-year total

Data: current Prescribed List · Calculations are based on published government data and figures you enter — a lookup and arithmetic tool, not regulatory or billing advice · Not an official government service.